Glenmark Pharmaceuticals Limited
Close-out letter issued October 3, 2019 · Mumbai, India
- Inspection
- Apr 15 – Apr 20, 2019
- Pages
- 5
- FEI number
- 3005757050
In short: On October 3, 2019, FDA sent Glenmark Pharmaceuticals Limited in Mumbai, India (FEI 3005757050) a close-out letter, confirming that the issues in an earlier warning letter were addressed.
Inside this close-out letter
The full close-out letter
Every page of the close-out letter, exactly as written.
Get the full close-out letterThis inspection in context
Questions about this close-out letter
When was Glenmark Pharmaceuticals Limited inspected by FDA?
The inspection ran Apr 15 – Apr 20, 2019, and the Close-out letter is dated October 3, 2019.
How do I get the full Close-out letter for Glenmark Pharmaceuticals Limited?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.